Article ISI SCOPUS
Human Vaccines and Immunotherapeutics  (2015)

Immunogenicity and safety of investigational vaccine formulations against meningococcal serogroups A, B, C, W, and Y in healthy adolescents

Saez-Llorens, X; Vaca, DCA; Abarca K.; Maho, E; Grana, MG; Heijnen, E; Smolenov, I; Dull, PM

Keywords: adolescents, safety, conjugate vaccine, immunogenicity, confidence interval, meningococcal disease, ae, neisseria meningitidis, pp, gmt, CI, nada, geometric mean titer, hSBA, serum bactericidal assay with human complement, IMD, invasive meningococcal disease, fHbp, factor H-binding protein, Neisseria adhesin A, NHBA, Neisserial Heparin Binding Antigen, OMV, outer membrane vesicle, per-protocol set, adverse event, SAE, serious adverse event